Position
Renaissance Technologies in Nephros Inc
Back to the book · All holders of NEPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $45.7K$2.98 → $3.57
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 103.8K | $506.4K | — | — | — | 0.0% |
| Q1 2026 | 99.4K | $296.2K | $2.98 | −$188.9K | −$21.3K | 0.0% |
| Q2 2026 | 77.5K | $276.7K | $3.57 | $45.7K | −$65.3K | 0.0% |